Frankfurt - Delayed Quote EUR

Achieve Life Sciences, Inc. (SP4P.F)

Compare
3.0450
+0.0150
+(0.50%)
At close: January 31 at 8:06:30 AM GMT+1
All numbers in thousands
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-24,945.0000
-24,479.0000
-37,569.0000
-29,440.0000
-13,474.0000
Investing Cash Flow
-33,303.0000
-21.0000
--
--
-17.0000
Financing Cash Flow
47,845.0000
15,278.0000
19,315.0000
36,610.0000
32,680.0000
End Cash Position
9,566.0000
15,596.0000
24,821.0000
43,072.0000
35,903.0000
Capital Expenditure
--
-21.0000
--
--
-17.0000
Issuance of Capital Stock
56,076.0000
15,301.0000
19,212.0000
21,343.0000
29,497.0000
Issuance of Debt
9,814.0000
--
--
14,929.0000
--
Repurchase of Capital Stock
--
-30.0000
--
--
--
Free Cash Flow
-24,951.0000
-24,500.0000
-37,569.0000
-29,440.0000
-13,491.0000
12/31/2020 - 12/28/2007

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade